临床前脓毒症研究的最低质量阈值(MQTiPSS):感染类型与器官功能障碍终点的质量要求
该文为Wiggers-Bernard会议关于临床前脓毒症建模的建议报告第二部分,基于2003至2012年间260篇高被引脓毒症模型论文的系统回顾。回顾显示44%的研究使用盲肠结扎穿刺模型,40%注射内毒素。报告提出建议8至13:内毒素注射不应被视为脓毒症模型,活菌或真菌株应来自临床分离株并复制人类脓毒症常见微生物;临床前模型应使用器官功能障碍定义,以客观可重复的评分系统测量,不要求所有实验测量所有参数但应尽可能全面捕获信息。这些建议作为动物脓毒症模型的「最佳实践」提出。
要点
- 建议8:内毒素注射不应被视为脓毒症模型,活菌或真菌株应来自临床分离株更合适。
- 建议9:微生物应复制人类脓毒症中通常发现的微生物。
- 建议10:临床前模型应使用器官功能障碍定义。
- 建议11:验证器官功能障碍不要求器官/系统的所有活动均异常。
- 建议12:器官功能障碍应以客观方式使用可重复的评分系统测量。
研究设计与关键结果
- Wiggers-Bernard会议系统回顾2003至2012年间260篇高被引脓毒症模型论文;盲肠结扎穿刺模型用于44%的研究,40%注射内毒素;回顾显示记录器官功能障碍的尝试有限。
证据类型、等级与局限
- 证据类型:会议建议(Wiggers-Bernard Conference);基于对260篇高被引论文的系统回顾;建议作为动物脓毒症模型的「最佳实践」提出;局限:原文未报告局限性。
对床旁实践的改变
- 作者建议临床前脓毒症研究不应使用内毒素注射作为脓毒症模型,应使用来自临床分离株的活菌或真菌并复制人类脓毒症常见微生物;应使用器官功能障碍定义并以客观可重复的评分系统测量,不要求所有实验测量所有参数但应尽可能全面捕获信息。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Although the clinical definitions of sepsis and recommended treatments are regularly updated, a systematic review has not been done for preclinical models. To address this deficit, a Wiggers-Bernard Conference on preclinical sepsis modeling reviewed the 260 most highly cited papers between 2003 and 2012 using sepsis models to create a series of recommendations. This Part II report provides recommendations for the types of infections and documentation of organ injury in preclinical sepsis models. Concerning the types of infections, the review showed that the cecal ligation and puncture model was used for 44% of the studies while 40% injected endotoxin. Recommendation #8 (numbered sequentially from Part I): endotoxin injection should not be considered as a model of sepsis; live bacteria or fungal strains derived from clinical isolates are more appropriate. Recommendation #9: microorganisms should replicate those typically found in human sepsis. Sepsis-3 states that sepsis is life-threatening organ dysfunction caused by a dysregulated host response to infection, but the review of the papers showed limited attempts to document organ dysfunction. Recommendation #10: organ dysfunction definitions should be used in preclinical models. Recommendation #11: not all activities in an organ/system need to be abnormal to verify organ dysfunction. Recommendation #12: organ dysfunction should be measured in an objective manner using reproducible scoring systems. Recommendation #13: not all experiments must measure all parameters of organ dysfunction, but investigators should attempt to fully capture as much information as possible. These recommendations are proposed as "best practices" for animal models of sepsis.
参考来源
- Wang L, Ren C, Yao R, et al. [Minimum quality threshold in preclinical sepsis studies (MQTiPSS): quality threshold for types of infections and organ dysfunction endpoints]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31771712. doi:10.3760/cma.j.issn.2095-4352.2019.10.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。